Factor v Leiden and MTHFR Mutations as a Combined Risk Factor for Hypercoagulability in Referred Patients Population From Western India

Molecular Cytogenetics - United Kingdom
doi 10.1186/1755-8166-7-s1-p28
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Factor v Leiden and Prothrombin 20210A Mutations Among Turkish Pediatric Leukemia Patients

Leukemia Research and Treatment
2012English

Factor v Leiden

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Cerebral Venous and Sinus Thrombosis and Thrombophilic Mutations in Western Iran: Association With Factor v Leiden

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2009English

The Effects of Factor v Leiden, Prothrombin G20210A, MTHFR C677T, MTHFR A1298C, Factor XIIIA Val34Leu, Factor XIIIB His95Arg and Apolipoprotein E Genotypes on Coronary Artery Disease

Turkish Journal of Biochemistry
BiochemistryClinical BiochemistryMolecular Biology
2012English

Prevalence of Factor v Leiden and Prothrombin 20210A Mutations in Indigenous Australians

Thrombosis and Haemostasis
Hematology
2001English

Tau Mutations as a Novel Risk Factor for Cancer—Letter

Cancer Research
Cancer ResearchOncology
2018English

Tau Mutations as a Novel Risk Factor for Cancer—Response

Cancer Research
Cancer ResearchOncology
2018English

Combined Deficiency of Factor v and Factor VIII

2020English

Factor v Arg306 THR (Factor v Cambridge) and Factor v Arg306 Gly Mutations in Venous Thrombotic Disease

British Journal of Haematology
Hematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy